Статья

Rapid high-yield expression of a candidate influenza vaccine based on the ectodomain of M2 protein linked to flagellin in plants using viral vectors

E. Mardanova, R. Kotlyarov, V. Kuprianov, L. Stepanova, L. Tsybalova, G. Lomonosoff, N. Ravin,
2021

Background: The extracellular domain of matrix protein 2 (M2e) of influenza A virus is a promising target for the development of a universal vaccine against influenza because M2e sequences are highly conserved among human influenza A strains. However, native M2e is poorly immunogenic, but its immunogenicity can be increased by delivery in combination with adjuvants or carrier particles. It was previously shown that fusion of M2e to bacterial flagellin, the ligand for Toll-like receptor (TLR) 5 and powerful mucosal adjuvant, significantly increases the immunogenicity and protective capacity of M2e. Results: In this study, we report for the first time the transient expression in plants of a recombinant protein Flg-4M comprising flagellin of Salmonella typhimurium fused to four tandem copies of the M2e peptide. The chimeric construct was expressed in Nicotiana benthamiana plants using either the self-replicating potato virus X (PVX) based vector, pA7248AMV-GFP, or the cowpea mosaic virus (CPMV)-derived expression vector, pEAQ-HT. The highest expression level up to 30% of total soluble protein (about 1mg/g of fresh leaf tissue) was achieved with the PVX-based expression system. Intranasal immunization of mice with purified Flg-4M protein induced high levels of M2e-specific serum antibodies and provided protection against lethal challenge with influenza virus. Conclusions: This study confirms the usefulness of flagellin as a carrier of M2e and its relevance for the production of M2e-based candidate influenza vaccines in plants. © 2015 Mardanova et al.

Цитирование

Похожие публикации

Документы

Источник

Версии

  • 1. Version of Record от 2021-04-27

Метаданные

Об авторах
  • E. Mardanova
    Centre 'Bioengineering', Russian Academy of Sciences, Prosp. 60-letya Oktyabrya, bld 7-1, Moscow, 117312, Russian Federation
  • R. Kotlyarov
    Research Institute of Influenza, Russian Federation Ministry of Health, 15/17 Prof. Popova str., St. Petersburg, 197376, Russian Federation
  • V. Kuprianov
    John Innes Centre, Department of Biological Chemistry, Norwich Research Park, Norwich, NR4 7UH, United Kingdom
  • L. Stepanova
  • L. Tsybalova
  • G. Lomonosoff
  • N. Ravin
Название журнала
  • BMC Biotechnology
Том
  • 15
Выпуск
  • 1
Страницы
  • -
Ключевые слова
  • Plants (botany); Proteins; Salmonella; Vaccines; Vectors; Viruses; Extracellular domains; Flagellin; Influenza; Intranasal immunizations; Potato virus x; Potato virus X-based vectors; Salmonella typhimurium; Viral vectors; Recombinant proteins; flagellin; flg 4m protein; green fluorescent protein; hybrid protein; influenza vaccine; protein M2; recombinant protein; unclassified drug; virus vector; flagellin; influenza vaccine; M2 protein, Influenza A virus; matrix protein; recombinant protein; animal experiment; animal model; antibody blood level; antigenicity; Article; avian influenza virus; controlled study; Cowpea mosaic virus; female; gene expression system; immune response; immunization; immunogenicity; infection prevention; influenza; influenza vaccination; mouse; Nicotiana benthamiana; nonhuman; plant leaf; plant tissue; Potato virus X; protein expression; Salmonella enterica serovar Typhimurium; virus replication; virus strain; animal; biosynthesis; chemistry; Comovirus; gene vector; genetics; human; immunology; intranasal drug administration; metabolism; Orthomyxoviridae Infections; physiology; plant virus; Potexvirus; tobacco; virology; Bacteria (microorganisms); Cowpea mosaic virus; Influenza A virus; Mus; Nicotiana benthamiana; Orthomyxoviridae; Potato virus X; Salmonella typhimurium; Administration, Intranasal; Animals; Comovirus; Flagellin; Genetic Vectors; Humans; Influenza Vaccines; Mice; Orthomyxoviridae Infections; Plant Viruses; Potexvirus; Recombinant Proteins; Salmonella typhimurium; Tobacco; Viral Matrix Proteins
Издатель
  • BioMed Central Ltd.
Тип документа
  • journal article
Тип лицензии Creative Commons
  • CC
Правовой статус документа
  • Свободная лицензия
Источник
  • scopus